Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

Cited by (415)

Items 101–200 of 415

1. D‐series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization
   Nicolas H. Pope, Morgan Salmon, John P. Davis, Anuran Chatterjee, Gang Su, Michael S. Conte, Gorav Ailawadi, Gilbert R. Upchurch · 2016 · The FASEB Journal
2. Emerging Roles of Eosinophils and Eosinophil-Derived Lipid Mediators in the Resolution of Inflammation
   Yosuke Isobe, Taiga Kato, Makoto Arita · 2012 · Frontiers in Immunology
3. Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke
   Valérie Capra, Magnus Bäck, Silvia Stella Barbieri, Marina Camera, Elena Tremoli, G. Enrico Rovati · 2012 · Medicinal Research Reviews
4. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis
   Amanda C. Doran, Lale Özcan, Bishuang Cai, Ze Zheng, Gabrielle Fredman, Christina C. Rymond, Bernhard Dorweiler, Judith C. Sluimer, Joanne Hsieh, George Kuriakose et al. · 2017 · Journal of Clinical Investigation
5. Resolvins: Natural agonists for resolution of pulmonary inflammation
   Mohib Uddin, Bruce D. Levy · 2010 · Progress in Lipid Research
6. Endogenously Decreasing Tissue n-6/n-3 Fatty Acid Ratio Reduces Atherosclerotic Lesions in Apolipoprotein E –Deficient Mice by Inhibiting Systemic and Vascular Inflammation
   Jian‐Bo Wan, Lili Huang, Rong Rong, Rui Tan, Jingdong Wang, Jing Xuan Kang · 2010 · Arteriosclerosis Thrombosis and Vascular Biology
7. Resolvin E1 Regulates Adenosine Diphosphate Activation of Human Platelets
   Gabrielle Fredman, Thomas E. Van Dyke, Charles Nicholas Serhan · 2010 · Arteriosclerosis Thrombosis and Vascular Biology
8. Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32
   Mattia Schmid, Claudio Gemperle, Nicole Rimann, Martin Hersberger · 2016 · The Journal of Immunology
9. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation
   Michael J. Zhang, Brian E. Sansbury, Jason L. Hellmann, James F. Baker, Luping Guo, Caitlin M. Parmer, Joshua C. Prenner, Daniel J. Conklin, Aruni Bhatnagar, Mark A. Creager et al. · 2016 · Circulation
10. Targeting Lipid Metabolism in Liver Cancer
    Malak Alannan, Hussein Fayyad‐Kazan, Véronique Trézéguet, Aksam J. Merched · 2020 · Biochemistry
11. Pathogenic stromal cells as therapeutic targets in joint inflammation
    Stephanie Georgina Dakin, Mark Christopher Coles, Jonathan P. Sherlock, Fiona M. Powrie, Andrew Jonathan Carr, Christopher Dominic Buckley · 2018 · Nature Reviews Rheumatology
12. Narrative Review of n-3 Polyunsaturated Fatty Acid Supplementation upon Immune Functions, Resolution Molecules and Lipid Peroxidation
    Gary Paul Zaloga · 2021 · Nutrients
13. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice
    Daisuke Akagi, Mian Chen, Robert Toy, Anuran Chatterjee, M. Conte · 2015 · The FASEB Journal
14. Metabolomics‐Lipidomics of Eicosanoids and Docosanoids Generated by Phagocytes
    Rong Yang, Nan Chiang, Sungwhan F. Oh, Charles Nicholas Serhan · 2011 · Current Protocols in Immunology
15. Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis
    Sarah A. Mattmiller, Bradley Allen Carlson, Lorraine M. Sordillo · 2013 · Journal of Nutritional Science
16. Lipoxin and Aspirin-Triggered Lipoxins
    Mario Romano · 2010 · The Scientific World JOURNAL
17. Specialized pro-resolving mediators in cardiovascular diseases
    Gabrielle Fredman, Matthew R. Spite · 2017 · Molecular Aspects of Medicine
18. Resolvin D4 attenuates the severity of pathological thrombosis in mice
    Deya Cherpokova, Charlotte Camille Jouvene, Stephania Libreros, Elise DeRoo, Long Chu, Xavier de la Rosa, Paul C. Norris, Denisa D. Wagner, Charles Nicholas Serhan · 2019 · Blood
19. Itaconate suppresses atherosclerosis by activating a Nrf2-dependent antiinflammatory response in macrophages in mice
    Jianrui Song, Yanling Zhang, Ryan A. Frieler, Anthony C. Andren, Sherri Chan Wood, Daniel J. Tyrrell, Peter Sajjakulnukit, Jane C. Deng, Costas Andreas Lyssiotis, Richard M. Mortensen et al. · 2023 · Journal of Clinical Investigation
20. Impact of Resolvin E1 on Murine Neutrophil Phagocytosis in Type 2 Diabetes
    Bruno S. Herrera, Hatice Hastürk, Alpdoğan Kantarcı, Marcelo Freire, Olivia Nguyen, Shevali Kansal, Thomas E. Van Dyke · 2014 · Infection and Immunity
21. Lipoxins: regulators of resolution
    Aidan Ryan, Catherine Godson · 2010 · Current Opinion in Pharmacology
22. Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future
    Yasuhiro Watanabe, Ichiro Tatsuno · 2017 · Expert Review of Clinical Pharmacology
23. 2016 Russell Ross Memorial Lecture in Vascular Biology
    Ira A. Tabas · 2016 · Arteriosclerosis Thrombosis and Vascular Biology
24. Hanging in the balance: endogenous anti‐inflammatory mechanisms in tissue repair and fibrosis
    Amiram Ariel, Orly Zeituni-Timor · 2012 · The Journal of Pathology
25. Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions
    Caroline N. Jones, Jesmond Dalli, Laurie Dimisko, Elisabeth A. Wong, Charles Nicholas Serhan, Daniel Irimia · 2012 · Proceedings of the National Academy of Sciences
26. Macrophage ADAM17 Deficiency Augments CD36-Dependent Apoptotic Cell Uptake and the Linked Anti-Inflammatory Phenotype
    Will S. Driscoll, Tomáš Vaisar, Jingjing Tang, Carole L. Wilson, Elaine W. Raines · 2013 · Circulation Research
27. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins
    Martin Hersberger · 2010 · Clinical Chemistry and Laboratory Medicine (CCLM)
28. EPA- and DHA-derived resolvins' actions in inflammatory bowel disease
    Raquel Cristina Schwanke, Rodrigo Marcon, Allisson Freire Bento, João Β. Calixto · 2015 · European Journal of Pharmacology
29. Short‐Term, High‐Dose Fish Oil Supplementation Increases the Production of Omega‐3 Fatty Acid–Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA‐PAD I Trial)
    S. Marlene Grenon, Christopher D. Owens, Emily V. Nosova, Millie Hughes‐Fulford, Hugh F. Alley, Karen C Chong, Sandra Perez, Priscilla K. Yen, W. John Boscardin, Jason L. Hellmann et al. · 2015 · Journal of the American Heart Association
30. Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction
    Maike Knorr, Thomas F. Münzel, Philip Wenzel · 2014 · Frontiers in Physiology
31. 4-Hydroxy Hexenal Derived from Docosahexaenoic Acid Protects Endothelial Cells via Nrf2 Activation
    Atsushi Ishikado, Katsutaro Morino, Yoshihiko Nishio, Fumiyuki Nakagawa, Atsushi Mukose, Yoko Sono, Yoshioka Nagisa, Keiko Kondo, Osamu Sekine, Takeshi Yoshizaki et al. · 2013 · PLoS ONE
32. Pro-resolving lipid mediators in vascular disease
    Michael S. Conte, Tejal Ashwin Desai, Bian Wu, Melinda S. Schaller, Evan C. Werlin · 2018 · Journal of Clinical Investigation
33. Constitutive and stimulated macropinocytosis in macrophages: roles in immunity and in the pathogenesis of atherosclerosis
    Sasha A. Doodnauth, Sergio Grinstein, Michelle E. Maxson · 2018 · Philosophical Transactions of the Royal Society B Biological Sciences
34. The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection
    Hildur Arnardottir, Silke Thul, Sven‐Christian Pawelzik, Glykeria Karadimou, Gonzalo Artiach, Alessandro L. Gallina, Victoria Mysdotter, Miguel Carracedo, Laura Tarnawski, April S. Caravaca et al. · 2021 · Journal of Clinical Investigation
35. Expression and regulation of 12/15-lipoxygenases in human primary macrophages
    Sophia Wüst, Margot Crucet, Claudio Gemperle, Christa Loretz, Martin Hersberger · 2012 · Atherosclerosis
36. Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells
    James F. Markworth, Lemuel A. Brown, Eunice Y. Lim, Carolyn Floyd, Jacqueline A. Larouche, Jesus A. Castor‐Macias, Kristoffer B. Sugg, Dylan C. Sarver, Peter C. D. Macpherson, Carol S. Davis et al. · 2020 · JCI Insight
37. Dual 12/15- and 5-Lipoxygenase Deficiency in Macrophages Alters Arachidonic Acid Metabolism and Attenuates Peritonitis and Atherosclerosis in ApoE Knock-out Mice
    Daniel Poeckel, Karin A. Zemski Berry, Robert C. Murphy, Colin D. Funk · 2009 · Journal of Biological Chemistry
38. Eicosanoids and cancer
    Renata Nascimento Gomes, Souza Felipe da Costa, Alison Colquhoun · 2018 · Clinics
39. Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells
    Atsushi Ishikado, Yoshihiko Nishio, Katsutaro Morino, Satoshi Ugi, Hajime KONDO, Taketoshi Makino, Atsunori Kashiwagi, Hiroshi Maegawa · 2010 · Biochemical and Biophysical Research Communications
40. Lipidomics applications for disease biomarker discovery in mammal models
    Ying‐Yong Zhao, Xian‐Long Cheng, Rui‐Chao Lin, Feng Wei · 2015 · Biomarkers in Medicine
41. Eliminating or blocking 12/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injury
    Jan Rossaint, Jerry L. Nadler, Klaus F. Ley, Alexander Zarbock · 2012 · Critical Care
42. Ageing: Is there a role for arachidonic acid and other bioactive lipids? A review
    Undurti Narasimha Das · 2018 · Journal of Advanced Research
43. Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells
    Tae Woo Jung, Hwan‐Jin Hwang, Ho Cheol Hong, Hae Yoon Choi, Hye Jin Yoo, Sei Hyun Baik, Kyung Mook Choi · 2014 · Molecular and Cellular Endocrinology
44. 12/15-Lipoxygenase during the regulation of inflammation, immunity, and self-tolerance
    Stefan Uderhardt, Gerhard Krönke · 2012 · Journal of Molecular Medicine
45. 15-oxo-Eicosatetraenoic Acid, a Metabolite of Macrophage 15-Hydroxyprostaglandin Dehydrogenase That Inhibits Endothelial Cell Proliferation
    Cong Wei, Peijuan Zhu, Sumit J. Shah, Ian A. Blair · 2009 · Molecular Pharmacology
46. Toll-Like Receptor-4 and Lipoprotein Accumulation in Macrophages
    Yury I. Miller, Soo-Ho Choi, Longhou Fang, Richard Harkewicz · 2009 · Trends in Cardiovascular Medicine
47. 15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?
    Sun IL Lee, Xiangsheng Zuo, Imad Shureiqi · 2011 · Cancer and Metastasis Reviews
48. Omega-3 fatty acids
    Chuchun L. Chang, Richard Joseph Deckelbaum · 2013 · Current Opinion in Lipidology
49. Roles and Mechanisms of Obstructive Sleep Apnea‐Hypopnea Syndrome and Chronic Intermittent Hypoxia in Atherosclerosis: Evidence and Prospective
    Lin-qin Ma, Jingchun Zhang, Yue Liu · 2016 · Oxidative Medicine and Cellular Longevity
50. Calcium signalling and ER stress in insulin resistance and atherosclerosis
    Lale Özcan, Ira A. Tabas · 2016 · Journal of Internal Medicine
51. Omega 3 Fatty Acid and Skin Diseases
    Yu Sawada, Natsuko Saito‐Sasaki, Motonobu Nakamura · 2021 · Frontiers in Immunology
52. Lipoxin A 4 Inhibits Porphyromonas gingivalis -Induced Aggregation and Reactive Oxygen Species Production by Modulating Neutrophil-Platelet Interaction and CD11b Expression
    Emma Börgeson, Johanna Lönn, Ida Bergström, Veronika Patcha Brodin, Sofia Ramström, Fariba Nayeri, Eva Särndahl, Torbjörn Bengtsson · 2011 · Infection and Immunity
53. Liver X Receptor Activation Promotes Polyunsaturated Fatty Acid Synthesis in Macrophages
    Alexis Varin, Charles Thomas, Minako Ishibashi, Louise Ménégaut, Thomas Gautier, Amalia Trousson, Victoria Bergas, Jean-Paul Paı̈s de Barros, Michel Narce, Jean‐Marc A. Lobaccaro et al. · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
54. Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response
    Pedro‐Antonio Regidor, Anna Mueller, Manuela Sailer, Fernando González Santos, Jose Miguel Rizo, Fernando Moreno Egea · 2020 · International Journal of Molecular Sciences
55. The fate of monocytes in atherosclerosis
    Gwendalyn J. Randolph · 2009 · Journal of Thrombosis and Haemostasis
56. Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response
    F. Chen, Xiaohua Fan, Yifan Wu, Jiali Zhu, Feibiao Wang, Lulong Bo, J. B. Li, Rui Bao, Xiaoming M. Deng · 2013 · European Journal of Clinical Microbiology & Infectious Diseases
57. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function
    Rima Chattopadhyay, Somasundaram Raghavan, Gadiparthi N. Rao · 2017 · Redox Biology
58. Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications
    Bian Wu, Giorgio Mottola, Melinda S. Schaller, Gilbert R. Upchurch, Michael S. Conte · 2017 · Molecular Aspects of Medicine
59. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation
    Charles Nicholas Serhan, Xavier de la Rosa, Charlotte Camille Jouvene · 2018 · Journal of Internal Medicine
60. Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation
    Stefania Lamon‐Fava, Jisun So, David Mischoulon, Thomas R. Ziegler, Boadie Waid Dunlop, Becky L. Kinkead, Pamela J. Schettler, Andrew Alan Nierenberg, Jennifer C. Felger, Krishna Rao Maddipati et al. · 2020 · Prostaglandins Leukotrienes and Essential Fatty Acids
61. Resolution of inflammation: targeting GPCRs that interact with lipids and peptides
    Jenna L. Cash, Lucy Victoria Norling, Mauro Perretti · 2014 · Drug Discovery Today
62. Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages and Supports Their Reprogramming
    Delphine Lumbroso, Soaad Soboh, Avi Maimon, Sagie Schif‐Zuck, Amiram Ariel, Tal Burstyn‐Cohen · 2018 · Frontiers in Immunology
63. Indole based peptidomimetics as anti-inflammatory and anti-hyperalgesic agents: Dual inhibition of 5-LOX and COX-2 enzymes
    Palwinder Singh, Parteek Prasher, Parvirti Dhillon, Rajbir Bhatti · 2015 · European Journal of Medicinal Chemistry
64. Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity
    Felice Simiele, Antonio Recchiuti, Domenico Mattoscio, Antonella De Luca, Eleonora Cianci, Sara Franchi, Valentina Gatta, Alessandro Parolari, José Pablo Werba, Marina Camera et al. · 2011 · The FASEB Journal
65. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury
    Bian Wu, Giorgio Mottola, Anuran Chatterjee, Kevin D. Lance, Mian Chen, Iris O. Siguenza, Tejal Ashwin Desai, Michael S. Conte · 2016 · Journal of Vascular Surgery
66. Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain
    Emre, Ceren, Hjorth, Erik, Bharani, Krishna, Carroll, Steven, Granholm, Ann‐Charlotte, Schultzberg, Marianne · 2020 · Brain Pathology
67. A defect in Δ6 and Δ5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians
    Undurti Narasimha Das · 2010 · Lipids in Health and Disease
68. Effects of resolvin D1 on inflammatory responses and oxidative stress of lipopolysaccharide-induced acute lung injury in mice
    Lei Wang, Ruixia Yuan, Chengyue Yao, Qingping Wu, Marie Christelle, Wanli Xie, Xingcai Zhang, Wei‐Zen Sun, Huiqing Wang, Shanglong Yao · 2014 · Chinese Medical Journal
69. IL‐10 mediates the immunoregulatory response in conjugated linoleic acid‐induced regression of atherosclerosis
    Cathal McCarthy, Michelle M. Duffy, Declan Mooney, William G. James, Matthew Dallas Griffin, Desmond J. Fitzgerald, Orina Belton · 2012 · The FASEB Journal
70. ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance
    Ivet Elias, Tura Ferré, Laia Vilà, SERGIO A. MUÑOZ, Alba Casellas, Miquel García, Maria Molas, Judith Agudo, Carles Roca, Jesús Ruberte et al. · 2016 · Diabetes
71. Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease
    Stanislav Nikolaevich Kotlyarov, Анна Анатольевна Котлярова · 2021 · International Journal of Molecular Sciences
72. Improved Survival and Reduced Vascular Permeability by Eliminating or Blocking 12/15-Lipoxygenase in Mouse Models of Acute Lung Injury (ALI)
    Alexander Zarbock, Matthew R. Distasi, Emily E. Smith, John M. Sanders, Gerhard Krönke, Brian L. Harry, Sibylle von Vietinghoff, Konrad Buscher, Jerry L. Nadler, Klaus F. Ley · 2009 · The Journal of Immunology
73. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways
    Juntao Xu, Xiaoru Duan, Feng Hu, Devesh Poorun, Xinxin Liu, Xin Wang, Song Zhang, Lu Gan, M. L. He, Ke Zhu et al. · 2017 · Journal of Dermatological Science
74. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
    Antonio Recchiuti, Domenico Mattoscio, Elisa Isopi · 2019 · Frontiers in Pharmacology
75. Roles of resolvins in the resolution of acute inflammation
    Qing Qu, Wenjuan Xuan, Guo-Huang Fan · 2014 · Cell Biology International
76. The Eicosanoids, Redox-Regulated Lipid Mediators in Immunometabolic Disorders
    Ana Carolina Justino de Araújo, Craig Edward Wheelock, Jesper Z. Haeggström · 2017 · Antioxidants and Redox Signaling
77. Effects of anti-inflammatory and adaptogenic herbal extracts on gene expression of eicosanoids signaling pathways in isolated brain cells
    Alexander George Panossian, Ean‐Jeong Seo, Thomas Efferth · 2019 · Phytomedicine
78. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect
    Gabrielle Fredman, Katherine C. MacNamara · 2021 · Cardiovascular Research
79. Resolvin D1 and its GPCRs in resolution circuits of inflammation
    Antonio Recchiuti · 2013 · Prostaglandins & Other Lipid Mediators
80. Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration
    Charles Nicholas Serhan, Nan Chiang · 2023 · Prostaglandins & Other Lipid Mediators
81. Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype
    Ran Rostoker, Hiba Yaseen, Sagie Schif‐Zuck, Rachel G. Lichtenstein, Gabriel A. Rabinovich, Amiram Ariel · 2013 · Prostaglandins & Other Lipid Mediators
82. ODC (Ornithine Decarboxylase)-Dependent Putrescine Synthesis Maintains MerTK (MER Tyrosine-Protein Kinase) Expression to Drive Resolution
    Arif Yurdagul, Na Kong, Brennan D. Gerlach, Xiaobo Wang, Patrick B. Ampomah, George Kuriakose, Wei Tao, Jinjun Shi, Ira A. Tabas · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
83. Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease
    Hernan A. Bazán, Yan Lu, Bokkyoo Jun, Zhide Fang, T. Cooper Woods, Song Hong · 2017 · Prostaglandins Leukotrienes and Essential Fatty Acids
84. Pro-resolving lipid mediators: Agents of anti-ageing?
    Ross Doyle, Denise M. Sadlier, Catherine Godson · 2018 · Seminars in Immunology
85. Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system
    Ahmed M. Darwesh, Deanna K. Sosnowski, Tim YT. Lee, Hedieh Keshavarz-Bahaghighat, John M. Seubert · 2019 · Chemico-Biological Interactions
86. Lipoxin A4 inhibits UV radiation-induced skin inflammation and oxidative stress in mice
    Renata Micheli Martinez, Victor Fattori, Priscila Saito, C.B.P. Melo, Sérgio M. Borghi, Ingrid C. Pinto, Allan J. C. Bussmann, Marcela Maria Baracat, Sandra R. Georgetti, Waldiceu Aparecido Verri Jr et al. · 2018 · Journal of Dermatological Science
87. Role of prostaglandin E2 in macrophage polarization: Insights into atherosclerosis
    Weixuan Wang, Mingjie Liang, Lexun Wang, Weijian Bei, Xianglu Rong, Jianqin Xu, Jiao Guo · 2022 · Biochemical Pharmacology
88. New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution
    Nella Prevete, Federica Liotti, Angela Amoresano, Piero Pucci, Amato de Paulis, Rosa Marina Melillo · 2017 · Pharmacological Research
89. Reduced macrophage selenoprotein expression alters oxidized lipid metabolite biosynthesis from arachidonic and linoleic acid
    Sarah A. Mattmiller, Bradley A. Carlson, Jeff C. Gandy, Lorraine M. Sordillo · 2014 · The Journal of Nutritional Biochemistry
90. Murine 12/15-Lipoxygenase Regulates ATP-binding Cassette Transporter G1 Protein Degradation through p38- and JNK2-dependent Pathways
    Melissa H. Nagelin, Suseela R. Srinivasan, Jerry L. Nadler, Catherine C. Hedrick · 2009 · Journal of Biological Chemistry
91. The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection
    Bruce David Levy, Qing yin Zhang, Caroline Bonnans, Valeria Primo, John J. Reilly, David L. Perkins, Yurong Liang, M. Amin Arnaout, Boris Nikolic, Charles Nicholas Serhan · 2010 · Prostaglandins Leukotrienes and Essential Fatty Acids
92. Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins
    Sajjad Chamani, Vanessa Bianconi, Aida Tasbandi, Matteo Pirro, George Emilio Barreto, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2020 · Mediators of Inflammation
93. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension
    Lucía Serrano Díaz del Campo, Ana B. García‐Redondo, Cristina Rodrı́guez, Carlos Zaragoza, Santiago Duro‐Sánchez, Francesco Palmas, Ángela de Benito-Bueno, Paula G. Socuéllamos, Diego Alberto Peraza, Raquel Rodrigues‐Díez et al. · 2022 · Hypertension
94. The role of omega-3 derived resolvins in arthritis
    Lucy Victoria Norling, Mauro Perretti · 2013 · Current Opinion in Pharmacology
95. Cinnamaldehyde protects VSMCs against ox-LDL-induced proliferation and migration through S arrest and inhibition of p38, JNK/MAPKs and NF-κB
    Weifeng Li, Wenbing Zhi, Jinmeng Zhao, Qing Yao, Fang Liu, Xiaofeng Niu · 2018 · Vascular Pharmacology
96. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model
    Bian Wu, Evan C. Werlin, Mian Chen, Giorgio Mottola, Anuran Chatterjee, Kevin D. Lance, Daniel A. Bernards, Brian E. Sansbury, Matthew R. Spite, Tejal Ashwin Desai et al. · 2018 · Journal of Vascular Surgery
97. Nutrigenetic Disruption of Inflammation-Resolution Homeostasis and Atherogenesis
    Aksam J. Merched, Charles Nicholas Serhan, Lawrence Chan · 2011 · Lifestyle Genomics
98. Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis
    Shunxing Rong, Qiang Cao, Mingxia Liu, Jeongmin Seo, Lin Jia, Elena Y. Boudyguina, Abraham K. Gebre, Perry L. Colvin, Thomas L. Smith, Robert C. Murphy et al. · 2012 · Journal of Lipid Research
99. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases
    Luíza Oliveira Perucci, Michelle A. Sugimoto, Karina Braga Gomes, Luci Maria Sant’Ana Dusse, Mauro Martins Teixeira, Lirlandia Pires Sousa · 2017 · Expert Opinion on Therapeutic Targets
100. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease
     Melinda S. Schaller, Mian Chen, Romain Alexandre Colas, Thomas A. Sorrentino, Ann Lazar, S. Marlene Grenon, Jesmond Dalli, Michael S. Conte · 2020 · Journal of the American Heart Association